HENNEMAN JOHN B III
SEC Form 4 insider trading activity
HENNEMAN JOHN B III has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including ANIK, APRE, OFIX, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.
On the most recent filing, HENNEMAN JOHN B III is listed as Director at Orthofix Medical Inc. Inside the rolling window, HENNEMAN JOHN B III reported 2 open-market purchases totaling $135K in OFIX and ANIK and no open-market sales. The largest disclosed transaction in the window is a purchase of 5,000 ANIK shares on May 1, 2026, worth $73K.
Companies traded
Other insiders at ANIK
Insider Buying
$135K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HENNEMAN JOHN B III made?
HENNEMAN JOHN B III has filed 5 SEC Form 4 filings (5 transaction rows) across 3 companies, including ANIK, APRE, OFIX since 2026.
Which companies does HENNEMAN JOHN B III trade?
HENNEMAN JOHN B III has filed SEC Form 4 disclosures for 3 companies, including ANIK, APRE, OFIX.
When was HENNEMAN JOHN B III's most recent SEC Form 4 filing?
HENNEMAN JOHN B III's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.
What is HENNEMAN JOHN B III's total buy and sell value in the current window?
Inside the rolling retention window, HENNEMAN JOHN B III bought $135K and sold $0 based on SEC Form 4 filings.
What was HENNEMAN JOHN B III's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 ANIK shares on 2026-05-01, worth $73K, per SEC Form 4 filings.